Acrivon Therapeutics, Inc. Common Stock
$2.18
-0.02 (-0.91%)
Price as of Aug 25, 2026 market close
Performance
- 1 Month
- +39.7%
- 3 Months
- +30.5%
- YTD
- -9.5%
- 1 Year
- +60.3%
Price return, based on split- and dividend-adjusted closing prices.
Risk
- Volatility 1-year annualized
- 95.0%
- Largest decline max drawdown, since Aug 2025
- -57.1%
- Risk-adjusted return Sharpe ratio, 1-year
- 0.97
Own ACRV?
See how ACRV contributes to your portfolio's return, allocation, and risk.
7-day free trial, then $9/month.